Vitamin D, innate immunity, and sarcoidosis granulomatous inflammation: Insights from mycobacterial research

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 5, 2010, Pages 461-464

  Richmond, Bradley W ^a   Drake, Wonder P ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

cathelicidin; innate immunity; sarcoidosis; vitamin D

Indexed keywords

CATHELICIDIN; VITAMIN D;

BACTERIAL VIRULENCE; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MYCOBACTERIOSIS; MYCOBACTERIUM; REVIEW; SARCOIDOSIS;

ANTIGENS, BACTERIAL; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; HYPERCALCEMIA; IMMUNITY, INNATE; MYCOBACTERIUM; SARCOIDOSIS, PULMONARY; VITAMIN D;

EID: 77955275394     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833af7e8     Document Type: Review

References (29)

1. Baehner RL, Nathan DG. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science 1967; 155:835-836.
2. Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-{kappa}B activation: common genetic etiology with Blau syndrome. Blood 2005; 105:1195-1197.
3. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005; 201:755-767.
4. Drake WP, Dhason MS, Nadaf M, et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007; 75:527-530.
5. Hajizadeh R, Sato H, Carlisle J, et al. Mycobacterium tuberculosis antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol 2007; 27:445-454.
6. Carlisle J, Evans W, Hajizadeh R, et al. Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 2007; 150:460-468.
7. Chen ES, Wahlstrom J, Song Z, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008; 181:8784-8796.
8. Nakata Y, Ejiri T, Kishi T, et al. Alveolar lymphocyte proliferation induced by Propionibacterium acnes in sarcoidosis patients. Acta Med Okayama 1986; 40:257-264.
9. Nakata Y, Ejiri T, Kishi T, et al. Alveolar lymphocyte proliferation in sarcoidosis patients induced by Propionibacterium acnes. Nihon Kyobu Shikkan Gakkai Zasshi 1985; 23:413-419.
10. Richter K, Culver D, Kasman LA, et al. Cellular responses to mycobacterial antigens are present in sarcoidosis diagnostic bronchoalveolar lavage. Infect Immun 2009; 77:3740-3748.
11. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 2009; 136:37-49.
12. Rook GA, Steele J, Fraher L, et al. Vitamin D3, interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57:159-163.
13. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37:113-119.
14. Cano MV, Ponce-de-Leon GF, Tippen S, et al. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect 2003; 131:907-914.
15. Gray GC, Fogle EF, Albright KL. Risk factors for primary pulmonary coccidioidomycosis hospitalizations among United States Navy and Marine Corps personnel, 1981-1994. Am J Trop Med Hyg 1998; 58:309-312.
16. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001; 32:708-715.
17. Flaherman VJ, Hector R, Rutherford GW. Estimating severe coccidioidomycosis in California. Emerg Infect Dis 2007; 13:1087-1090.
18. Wheat LJ, Slama TG, Eitzen HE, et al. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med 1981; 94:331-337.
19. Wheat LJ, Chetchotisakd P, Williams B, et al. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30:877-881.
20. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336:1224-1235.
21. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-632.
22. Edmondstone WM, Wilson AG. Sarcoidosis in caucasians, blacks, and Asians. Br J Dis Chest 1985; 79:27-36.
23. Benatar SR. Sarcoidosis in South Africa: a comparative study in whites, blacks, and coloureds. S Afr Med J 1977; 52:602-606.
24. Rybicki BA, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 148:234-241.
25. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective. J Nutr 2005; 135:310-316.
26. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-1773.
27. Kanchwala AA, Barna BP, Singh RJ, et al. Deficiencies of cathelicidin and vitamin D accompany disease severity in sarcoidosis. Am J Respir Crit Care Med 2009; 179:A3997.
28. Agerberth B, Grunewald J, Castanos-Velez E, et al. Antibacterial components in bronchioalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med 1999; 160:283-290.
29. Swaisgood C, Oswald-Richter K, Moeller SD, et al. Development of a sarcoidosis murine lung granuloma model using Mycobacterium sodA. Am J Respir Cell Mol Biol 2010 [Epub ahead of print].